Information on the following pages is cited from the Local Coverage Determinations / Supporting Information of the individual state and reflects the coverage specific to the Medicare insurance Carrier or Fiscal Intermediary, or Medicare Administrative Contractor (MAC) of that state. Janssen Biotech, Inc. has no responsibility for the LCDs and/or the information contained therein. This information may not be consistent with the current DOXIL® (doxorubicin HCl liposome injection) prescribing information and is not intended as an endorsement and makes no representations regarding any usage which is inconsistent with the FDA-approved prescribing information.


State Medicare Guidelines / CMS 1500

Kentucky

Print

STATE MEDICARE PAYERS

MAC Part A and Part B
CGS Administrators, LLC

Legal Notice: This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws, regulations and policies concerning reimbursement are complex and are updated frequently. While we have made an effort to be current as of the issue date of this document, the information may not be as current or comprehensive when you view it. Please consult with your counsel or reimbursement specialist for any reimbursement or billing questions.


Part A - Updated January 22, 2014

For additional information on Medicare-covered indications for your specific state, please see the appropriate Part A Local Coverage Determinations/Supporting Documentation, which may be accessed through the link above or by clicking here - Part A.

For claims on or after July 1, 2013, use Q2050. From January 1-June 30, 2013, use J9002. From July 1-December 31, 2012, use Q2048. For details click on the DOXIL® Code Change Flashcard, or review the CMS documentation.

Indication ICD-9-CM HCPCS
Kaposi's Sarcoma Not Stated Q2050
Link
Ovarian Cancer Not Stated Q2050
Link
R84

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call DOXILine® at 1-800-609-1083 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.

Back to Top


Part B - Updated January 22, 2014

For additional information on Medicare-covered indications for your specific state, please see the appropriate Part B Local Coverage Determinations/Supporting Documentation, which may be accessed through the link above or by clicking here - Part B.

For claims on or after July 1, 2013, use Q2050. From January 1-June 30, 2013, use J9002. From July 1-December 31, 2012, use Q2048. For details click on the DOXIL® Code Change Flashcard, or review the CMS documentation.

Indication ICD-9-CM HCPCS
Kaposi's Sarcoma Not Stated Q2050
Link
Ovarian Cancer Not Stated Q2050
Link
R84

These summaries have been prepared using the Medicare guidelines. If you would like to receive the Medicare guidelines, you can call DOXILine® at 1-800-609-1083 or you can contact the Medicare contractor directly at the web address in the State Medicare Payers box above.

Back to Top

March 18, 2014